BASILIXIMAB vs BELANTAMAB MAFODOTIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BASILIXIMAB vs BELANTAMAB MAFODOTIN: Safety Overview
| Metric | BASILIXIMAB | BELANTAMAB MAFODOTIN |
|---|---|---|
| Total FAERS Reports | 6,817 | 2,293 |
| Deaths Reported | 1,507 | 843 |
| Death Rate | 22.1% | 36.8% |
| Hospitalizations | 2,802 | 599 |
| Average Patient Age | 44.2 yrs | 67.3 yrs |
| % Female Patients | 35.9% | 39.2% |
| Manufacturer | Novartis Pharmaceuticals Corporation | GlaxoSmithKline LLC |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Prescription | N/A |